Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NetraMark Holdings (AINMF)
OTHER OTC:AINMF
NetraMark Holdings (AINMF) Stock Price & Analysis
2 Followers
AINMF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.14 - $0.36
Previous Close$0.2
Volume587.00
Average Volume (3M)6.98K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$259.85K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding67,379,355
10 Day Avg. Volume5,550
30 Day Avg. Volume6,977
Standard Deviation0.37
R-Squared0.00148
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)32.32
Price to Sales (P/S)167.19
Price to Cash Flow (P/CF)-5.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NetraMark Holdings News
PremiumCompany Announcements
NetraMark’s AI to Transform Psychiatric Research
PremiumCompany Announcements
NetraMark Unveils AI-Driven Clinical Trial Breakthrough
PremiumCompany Announcements
NetraMark’s AI Revolutionizes Cancer Biomarker Discovery
PremiumCompany Announcements
NetraMark Shareholders Approve Key Resolutions
PremiumCompany Announcements
NetraMark Enhances Board with Pharma ExpertPremiumCompany Announcements
NetraMark Revolutionizes AI in Clinical Trials
PremiumCompany Announcements
NetraMark’s AI to Revolutionize Clinical TrialsPremiumCompany Announcements
NetraMark Unveils AI Breakthrough in Parkinson’s ResearchOptions Prices
Currently, No data available
---
Ownership Overview
25.83% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
74.17% Public Companies and
Individual Investors
AINMF FAQ
What was NetraMark Holdings’s price range in the past 12 months?
NetraMark Holdings lowest stock price was $0.14 and its highest was $0.35 in the past 12 months.
What is NetraMark Holdings’s market cap?
Currently, no data Available
When is NetraMark Holdings’s upcoming earnings report date?
NetraMark Holdings’s upcoming earnings report date is Aug 26, 2024 which is in 32 days.
How were NetraMark Holdings’s earnings last quarter?
NetraMark Holdings released its earnings results on May 13, 2024. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
Is NetraMark Holdings overvalued?
According to Wall Street analysts NetraMark Holdings’s price is currently Overvalued.
Does NetraMark Holdings pay dividends?
NetraMark Holdings does not currently pay dividends.
What is NetraMark Holdings’s EPS estimate?
NetraMark Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetraMark Holdings have?
NetraMark Holdings has 67,379,360 shares outstanding.
What happened to NetraMark Holdings’s price movement after its last earnings report?
NetraMark Holdings reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.348%.
Which hedge fund is a major shareholder of NetraMark Holdings?
Currently, no hedge funds are holding shares in AINMF
---
NetraMark Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.90%
12-Months-Change
Fundamentals
Return on Equity
-293.90%
Trailing 12-Months
Asset Growth
-94.80%
Trailing 12-Months
Company Description
NetraMark Holdings
Nurosene Health Inc is a technology-driven wellness company focused on providing healthy habits focused on the mind, body and brain to improve daily mental wellness and overall brain health. It has launched its Mobile Application, which provides users with habit-forming strategies, along with a line of proprietary nutraceutical supplements which have been formulated to support a healthy life through targeting specific cell structures and their inherent functions.
---
Technical Analysis
---